Literature DB >> 7151278

Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders.

M Ichinose, K Miki, C Furihata, T Kageyama, R Hayashi, H Niwa, H Oka, T Matsushima, K Takahashi.   

Abstract

A radioimmunoassay (RIA) for human group I pepsinogens (PgI) in serum was developed, using PgI purified from gastric mucosa. The sensitivity (0.7 micrograms/l) and reproducibility of the assay were satisfactory for clinical use. In normal controls, total serum pepsinogen (T-Pg) level was 58.9 +/- 31.7 micrograms/l (mean +/- SD) (PgI, 43.6 +/- 25.0 micrograms/l; PgII, 15.3 +/- 11.1 micrograms/l). Peptic ulcer cases had elevated T-Pg levels (gastric ulcer, gastroduodenal ulcer and duodenal ulcer, in increasing order of magnitude). T-Pg levels were not useful for diagnosis of peptic ulcer because of a large overlap with normal controls. T-Pg levels were low in patients with gastric polyp and in aged subjects. In these groups, the decrease of PgI was more marked than that of PgII.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7151278     DOI: 10.1016/0009-8981(82)90034-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  43 in total

1.  Accuracy of screening for gastric cancer using serum pepsinogen concentrations.

Authors:  F Kitahara; K Kobayashi; T Sato; Y Kojima; T Araki; M A Fujino
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

2.  Analysis of ABC (D) stratification for screening patients with gastric cancer.

Authors:  Tomohiro Kudo; Satoru Kakizaki; Naondo Sohara; Yasuhiro Onozato; Shinichi Okamura; Yoshikatsu Inui; Masatomo Mori
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

3.  Gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

4.  Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia.

Authors:  H Osawa; F Inoue; Y Yoshida
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

5.  Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan.

Authors:  Y Watanabe; J H Kurata; S Mizuno; M Mukai; H Inokuchi; K Miki; K Ozasa; K Kawai
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

6.  Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis.

Authors:  S Nakamura; T Matsumoto; Y Kobori; M Iida
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

7.  Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis.

Authors:  Yoshihisa Urita; Kazuo Hike; Naotaka Torii; Yoshinori Kikuchi; Eiko Kanda; Masahiko Sasajima; Kazumasa Miki
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

8.  Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication.

Authors:  Katsunori Iijima; Tomoyuki Koike; Yasuhiko Abe; Nobuyuki Ara; Kaname Uno; Akira Imatani; Shuichi Ohara; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2009-05-14       Impact factor: 7.527

9.  Serum pepsinogen in screening for gastric cancer.

Authors:  A Kodoi; M Yoshihara; K Sumii; K Haruma; G Kajiyama
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

10.  Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in Thais.

Authors:  Sirikan Yamada; Takeshi Matsuhisa; Luksana Makonkawkeyoon; Suparp Chaidatch; Shunji Kato; Norio Matsukura
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.